Gradient line
BioTransfer 2009   |   Contacts   
Gradient line
button Home button Co-organizers button Partners button Program button Registration bouton Networking button Portfolio
Gradient line

Co-organizers Technology Portfolio

Co-organizers
NRC Biotechnology Research Institute (NRC-BRI)
NRC Institute for Biological Sciences (NRC-IBS)
McGill University and the Research Institute of the McGill University Health Centre   Montreal Excellerator
Gestion Univalor, Limited Partnership   Université de Montréal and Affiliated Hospital Centres
The Massachusetts Technology Transfer Center

Co-organizers Technology Portfolio Login


The Massachusetts Technology Transfer Center
Technology Portfolio
ID #TitlePDFVideoInformation Request
MTTC-UMassMed Novel HIV-1 Protease Inhibitors
MTTC-Tufts Atoxic Recombinant Holotoxins of Clostridium Difficile as Immunogens
MTTC-Harvard Platform Technology for Small Molecule Modulators of Autophagy
MTTC-Children's Lodamin: a novel oral drug for oncology, ophthalmology and autoimmune diseases
MTTC-Broad Gene-expression signatures that identify cirrhosis patients "at risk" for liver cancer and predict the probability of HCC recurrence following early-stage diagnosis and resection
MTTC-Brigham Novel HSV2 Vaccine Technology
MTTC-6 Angiogenin as a Potential Therapy for ALS
MTTC-5 Extract-based Functional Assay (EFA) for the Detection of Post-Translational Modifications
MTTC-4 Detection of Solid Tumor Signatures in Blood of Cancer Patients
MTTC-3 High-Throughput Screening Tools for Disruptors of Meiosis and Fat Homeostasis
MTTC- Whitehead Expansion of Hematopoeitic Stem Cells
blank spaceFooter Line
 
Date Modified: 2009-12-04
Top of page